US2023210396A1PendingUtilityA1

Machine learning spectral ffr-ct

Assignee: KONINKLIJKE PHILIPS NVPriority: Jun 30, 2017Filed: Mar 9, 2023Published: Jul 6, 2023
Est. expiryJun 30, 2037(~10.9 yrs left)· nominal 20-yr term from priority
G06N 20/00G06F 30/27G06T 5/50A61B 5/026G06T 2207/10081G06T 7/0012G06T 2207/30104A61B 6/032A61B 6/4014A61B 6/405A61B 6/4241A61B 6/482A61B 6/504A61B 6/5217G16H 50/50G16H 30/40G16H 50/70Y02A90/10
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

One embodiment of the present invention includes a computer-implemented method that includes receiving spectral computed tomography (CT) volumetric image data. The spectral CT volumetric image data include data for at least two different energies and/or energy ranges. The spectral CT volumetric image data is processed with a machine learning engine configured to map spectrally enhanced features extracted from the spectral CT volumetric image data onto fractional flow reserve (FFR) values to determine a FFR value. The FFR value is then visually presented.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A computer-implemented method, comprising:
 receiving spectral computed tomography (CT) volumetric image data, wherein the spectral CT volumetric image data include data for at least two different energies and/or energy ranges;   processing the spectral CT volumetric image data with a machine learning engine configured to map spectrally enhanced features extracted from the spectral CT volumetric image data onto fractional flow reserve (FFR) values to determine a FFR value; and   visually presenting the FFR value.   
     
     
         2 . The method according to  claim 1 , further comprising extracting a spectral morphological feature by detecting, segmenting and classifying using the spectral volumetric image data. 
     
     
         3 . The method according to  claim 1 , wherein the spectrally enhanced physiological feature includes a quantity related to coronary blood flow. 
     
     
         4 . The method according to  claim 3 , wherein the spectrally enhanced physiological feature includes one or more of a spectral myocardium deficit or a spectral collateral flow. 
     
     
         5 . The method according to  claim 1 , further comprising extracting a feature from the spectral CT volumetric image data, wherein the extracted feature includes at least one of a spectrally enhanced anatomical feature, a spectrally enhanced plaque morphological and functional feature, and a spectrally enhanced physiological feature. 
     
     
         6 . The method according to  claim 5 , wherein the spectrally enhanced anatomical feature includes a geometrical and topological feature. 
     
     
         7 . The method according to  claim 6 , further comprising enhancing an anatomical feature using different spectral images to determine a presence of different anatomical tissue of a coronary tree anatomy. 
     
     
         8 . The method according to  claim 6 , further comprising enhancing an anatomical feature using different mono-energetic images to find a boundary between different anatomical tissue of a coronary tree anatomy. 
     
     
         9 . The method according to  claim 6 , further comprising enhancing an anatomical feature using spectrally enabled regularization. 
     
     
         10 . The method according to  claim 1 , wherein the machine learning engine estimates the FFR value at a predetermined location of a coronary tree by applying a function on a feature describing the predetermined location. 
     
     
         11 . The method according to  claim 10 , wherein the function describes a statistical relationship between the feature and the FFR value.

Join the waitlist — get patent alerts

Track US2023210396A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.